CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Venus Medtech (Hangzhou) Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Venus Medtech (Hangzhou) Inc
Room 311, 3/F, Block 2, No. 88
Jiangling Road, Binjiang District
HANGZHOU, ZHJ  China Ticker: 25002500
Business Summary
Venus Medtech (Hangzhou) Inc is a China-based company primarily engaged in the research, development, production, and sales of biological heart valves. The Company focuses on the field of structural heart disease. The Company's products include a series of interventional devices for heart valve diseases, such as transcatheter aortic valve replacement (TAVR), transcatheter pulmonary valve replacement (TPVR), transcatheter mitral valve replacement (TMVR), and transcatheter tricuspid valve replacement (TTVR), as well as surgical consumables. The Company distributes its products within the domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2024Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Ting YukWu 71 12/15/2023 11/1/2018
Executive Director, Vice President of Clinical Medicine MaLiqiao 40 12/15/2023 1/1/2019
Vice President, Executive Director LiuMeirong 49 1/30/2023 1/30/2023
6 additional Officers and Directors records available in full report.

Business Names
Business Name
2500
Cardiovalve Ltd.

General Information
Number of Employees: 560 (As of 12/31/2025)
Outstanding Shares: 441,011,443 (As of 12/31/2025)
Stock Exchange: HKG


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 29, 2026